NeoClone Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Out of Business

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Out of Business

NeoClone General Information

Description

Developer of monoclonal antibodies intended for use in biotechnology and research applications. The company's platform utilizes retroviral transformation technology to produce monoclonal antibodies, offering faster development times and cost savings, enabling the company to provide customized antibodies to researchers and scientists at an accelerated pace and with cost efficiency.

Contact Information

Website
www.neoclone.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 1202 Ann Street
  • Madison, WI 53713
  • United States
+1 (608)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 1202 Ann Street
  • Madison, WI 53713
  • United States
+1 (608)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NeoClone Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Out of Business 13-Aug-2025 Completed Out of Business
6. Secondary Transaction - Private 01-Oct-2021 Completed Generating Revenue
5. Later Stage VC 12-Jan-2013 Completed Generating Revenue
4. Grant 01-Sep-2012 Completed Generating Revenue
3. Later Stage VC 01-Mar-2011 Completed Generating Revenue
2. Debt - General $550K $550K Completed Startup
1. University Spin-Out 01-Jan-1999 Completed Startup
To view NeoClone’s complete valuation and funding history, request access »

NeoClone Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of monoclonal antibodies intended for use in biotechnology and research applications. The company's platform u
Drug Discovery
Madison, WI
5 As of 2023

San Diego, CA
 

Lebanon, NH
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

NeoClone Competitors (24)

One of NeoClone’s 24 competitors is Vividion Therapeutics, a Formerly VC-backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vividion Therapeutics Formerly VC-backed San Diego, CA
Adimab Venture Capital-Backed Lebanon, NH
GenScript Formerly VC-backed Nanjing, China
Cell Signaling Technology Corporation Danvers, MA
Abnova (Taiwan) Corporation Taipei, Taiwan
You’re viewing 5 of 24 competitors. Get the full list »

NeoClone Patents

  • 3

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

NeoClone Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20130177987-A1 Methods for developing antigen-specific antibody-producing cell lines and monoclonal antibodies Inactive 24-Jun-2011
WO-2012178150-A2 Methods for developing antigen-specific antibody-producing cell lines and monoclonal antibodies Inactive 24-Jun-2011
WO-2012178150-A3 Methods for developing antigen-specific antibody-producing cell lines and monoclonal antibodies Inactive 24-Jun-2011 C12N5/0648

NeoClone Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

NeoClone FAQs

  • When was NeoClone founded?

    NeoClone was founded in 1999.

  • Where is NeoClone headquartered?

    NeoClone is headquartered in Madison, WI.

  • What is the size of NeoClone?

    NeoClone has 5 total employees.

  • What industry is NeoClone in?

    NeoClone’s primary industry is Drug Discovery.

  • Is NeoClone a private or public company?

    NeoClone is a Private company.

  • What is NeoClone’s current revenue?

    The current revenue for NeoClone is .

  • How much funding has NeoClone raised over time?

    NeoClone has raised $1.6M.

  • Who are NeoClone’s competitors?

    Vividion Therapeutics, Adimab, GenScript, Cell Signaling Technology, and Abnova (Taiwan) are some of the 24 competitors of NeoClone.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process